Claritev Corporation Announces Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

MCLEAN, Va., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights company, today announced that members of its management team will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Wednesday, November 11, 2026, in New York, including a presentation at 3:30 p.m. ET.

To listen to the webcast, please visit https://investors.claritev.com/. For one-on-one meetings, please contact a representative at the host firm.

About Claritev

Claritev is a healthcare technology, data, and insights company focused on delivering affordability, transparency, and quality across the U.S. healthcare system. Led by deeply experienced associates, data scientists, and innovators, Claritev provides technology-enabled solutions fueled by decades of claims expertise. The company leverages advanced analytics and AI to power a robust enterprise platform that delivers clear, actionable insights to support affordability, price transparency, and optimized network and benefits design. By supporting key stakeholders, including payers, employers, patients, providers, and third parties, Claritev is dedicated to making healthcare more accessible and affordable for all.

Claritev serves more than 750 healthcare payers, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

Investor Relations Contacts
Todd Friedman
Head of Investor Relations and Strategic Communications
Claritev
investor@claritev.com

Media Relations Contact
Jen O’Connor
VP, Brand Marketing
Claritev
press@claritev.com

Source: Claritev Corporation